 |
|
Pioglitazone as risky as rosiglitazone, study finds
[Wertz DA et al. Circulation: Cardiovascular Quality and Outcomes. Aug 24, 2010
|
Report] |
|
|
|
|
 |
|
Angiotensin-receptor blockade may increase the risk of cancer
[Sipahi I et al. Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials.
Lancet Oncol. 2010 Jul;11(7):627-636. Epub 2010 Jun 11.] |
|
|
|
|
 |
|
FDA Documents Find Significant Risks for Rosiglitazone
[See
1,
2,
3,
4,
5,6,
7] [Updated
Aug 1, 2010] |
|
|
|
|
 |
|
Statins may increase diabetes risk
[Naveed Sattar et al. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
The Lancet, 17 February 2010 | Reuters Report] |
|
|
|
|
 |
|
Thiazolidinedione Use Increases Risk of Fractures in Patients with Type 2 Diabetes Mellitus
[Zeina A. Habib et al. The Journal of Clinical Endocrinology & Metabolism Feb 2009;95(2):592-600][More] |
|
|
|
|
 |
|
Oseltamivir neither effective nor safe: BMJ
[BMJ Dec 8, 2009] |
|
|
|
|
 |
|
Diclofenac may cause liver failure
[FDA
Alert] |
|
|
|
|
 |
|
PPIs reduce the efficacy of Clopidogrel
[FDA
Alert;
FDA Alert] |
|
|
|
|
 |
|
No checks on drug companies bribing doctors
[See Report] |
|
|
|
|
 |
|
Swine flu vaccine approved without adequate tests
[FDA Approval;
Product Details] |
|
|
|
|
 |
|
Swine flu vaccine may cause neuromuscular paralysis
: Leaked letter reveals concern of neurologists over 25 deaths in America
[See Report] |
|
|
|
|
 |
|
FDA Warns of Increased Cancer Risk With TNF Blockers in Children
[See FDA,
Report] |
|
|
|
|
 |
|
Wyeth used ghost writers to promote HRT
[See 1,
2,
3,
4] |
|
|
|
|
 |
|
Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone
[See BMJ,
Report] |
|
|
|
|
 |
|
Increased risk of cancer with TNF blockers, warns FDA
[See 1,
2,
3] |
|
|
|
|
 |
|
Insulin Analogue Glargine Possibly Increases Cancer Risk
[See 1, 2] |
|
|
|
|
 |
|
Chantix and Zyban to Receive Boxed Warnings for Serious Neuropsychiatric Symptoms
[See] |
|
|
|
|
 |
|
FDA May Restrict Acetaminophen
[See] |
|
|
|
|
 |
|
New Safety Labeling for Leukotriene Modifiers
[See] |
|
|
|
|
 |
|
More Evidence Links Glitazones to Broken Bones
[See] |
|
|
|
|
 |
|
HRT Increases Risk for Death from Non-Small-Cell Lung Cancer
[See] |
|
|
|
|
 |
|
British scientists ask WHO to condemn homeopathy for diseases such as HIV
[See] |
|
|
|
|
 |
|
The
Lancet critique on Bill & Melinda Gates Foundation
grant pattern
[See;
See Report] |
|
|
|
|
 |
|
Elsevier published 6 fake journals
[See
|
More] |
|
|
|
|
 |
|
Efalizumab being withdrawn from U.S. market following PML cases
[See
|
More] |
|
|
|
|
 |
|
Celecoxib: A big research fraud stands exposed
[R Prasad :: The Hindu
|
Editorial ::The Hindu] |
|
|
|
|
 |
|
Reducing Heart Rate in Hypertension May Be Harmful
[See] |
|
|
|
|
 |
|
Muscle Pain and Weakness With Statin Treatment May Herald ALS
[See] |
|
|
|
|
 |
|
Ipratopium Linked to Increased Mortality Risk
[See] |
|
|
|
|
 |
|
FDA Is Watching 20 Drugs
[See] |
|
|
|
|
 |
|
FDA Investigating Possible Link Between Ezetimibe/Simvastatin and Increased
Cancer Risk
[FDA
|
Report |
Report] |
|
|
|
|
 |
|
Review of the Use of Muscle Relaxants for Musculoskeletal Conditions |
|
|
|
|
 |
|
FDA Requests Boxed Warnings on Fluoro-quinolone Antimicrobial Drugs |
|
|
|
|
 |
|
Rosiglitazone-Associated Fractures in Type 2 Diabetes |
|
|
|
|
 |
|
Anti depressants no better than placebo |
|
|
|
|
 |
|
Possible Link Between Montelukast and Suicidality: Early Communication About an Ongoing Safety Review by US FDA |
|
|
|
|
 |
|
Exenatide may cause pancreatitis:
FDA reviews 30 postmarketing reports |
|
|
|
|
 |
|
Information on Long-Acting Hydrocodone-Containing Cough Product |
|
|
|
|
 |
|
COX-2 Selective and Non-Selective Non-Steroidal Anti-Inflammatory
Drugs (NSAIDs) increase risk for cardiovascular events |
|
|
|
|
 |
|
NIH Halts Use of COX-2 Inhibitor in Large Cancer Prevention Trial |
|
|
|
|
 |
|
MRI Not Required for Knee Osteoarthritis, Study Suggests |